These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 20599439

  • 1. Pharmacokinetics of acute and sub-chronic aripiprazole in P-glycoprotein deficient mice.
    Kirschbaum KM, Uhr M, Holthoewer D, Namendorf C, Pietrzik C, Hiemke C, Schmitt U.
    Neuropharmacology; 2010 Nov; 59(6):474-9. PubMed ID: 20599439
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacodynamic effects of aripiprazole and ziprasidone with respect to p-glycoprotein substrate properties.
    Holthoewer D, Kirschbaum KM, Frisch J, Hiemke C, Schmitt U.
    Pharmacopsychiatry; 2013 Jul; 46(5):175-80. PubMed ID: 23737243
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Impact of genetic deficiencies of P-glycoprotein and breast cancer resistance protein on pharmacokinetics of aripiprazole and dehydroaripiprazole.
    Nagasaka Y, Sano T, Oda K, Kawamura A, Usui T.
    Xenobiotica; 2014 Oct; 44(10):926-32. PubMed ID: 24666334
    [Abstract] [Full Text] [Related]

  • 6. Species comparison of in vivo P-glycoprotein-mediated brain efflux using mdr1a-deficient rats and mice.
    Bundgaard C, Jensen CJ, Garmer M.
    Drug Metab Dispos; 2012 Mar; 40(3):461-6. PubMed ID: 22112383
    [Abstract] [Full Text] [Related]

  • 7. Blonanserin, a novel atypical antipsychotic agent not actively transported as substrate by P-glycoprotein.
    Inoue T, Osada K, Tagawa M, Ogawa Y, Haga T, Sogame Y, Hashizume T, Watanabe T, Taguchi A, Katsumata T, Yabuki M, Yamaguchi N.
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct 01; 39(1):156-62. PubMed ID: 22691713
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. P-glycoprotein (ABCB1) transports the primary active tamoxifen metabolites endoxifen and 4-hydroxytamoxifen and restricts their brain penetration.
    Iusuf D, Teunissen SF, Wagenaar E, Rosing H, Beijnen JH, Schinkel AH.
    J Pharmacol Exp Ther; 2011 Jun 01; 337(3):710-7. PubMed ID: 21378205
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics and pharmacodynamics of alfentanil in P-glycoprotein-competent and P-glycoprotein-deficient mice: P-glycoprotein efflux alters alfentanil brain disposition and antinociception.
    Kalvass JC, Olson ER, Pollack GM.
    Drug Metab Dispos; 2007 Mar 01; 35(3):455-9. PubMed ID: 17178769
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. P-glycoprotein efflux at the blood-brain barrier mediates differences in brain disposition and pharmacodynamics between two structurally related neurokinin-1 receptor antagonists.
    Smith BJ, Doran AC, McLean S, Tingley FD, O'Neill BT, Kajiji SM.
    J Pharmacol Exp Ther; 2001 Sep 01; 298(3):1252-9. PubMed ID: 11504828
    [Abstract] [Full Text] [Related]

  • 14. Efflux transport of a new quinolone antibacterial agent, HSR-903, across the blood-brain barrier.
    Murata M, Tamai I, Kato H, Nagata O, Tsuji A.
    J Pharmacol Exp Ther; 1999 Jul 01; 290(1):51-7. PubMed ID: 10381759
    [Abstract] [Full Text] [Related]

  • 15. The role of p-glycoprotein in limiting brain penetration of the peripherally acting anticholinergic overactive bladder drug trospium chloride.
    Geyer J, Gavrilova O, Petzinger E.
    Drug Metab Dispos; 2009 Jul 01; 37(7):1371-4. PubMed ID: 19389858
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Altered brain concentrations of citalopram and escitalopram in P-glycoprotein deficient mice after acute and chronic treatment.
    Karlsson L, Carlsson B, Hiemke C, Ahlner J, Bengtsson F, Schmitt U, Kugelberg FC.
    Eur Neuropsychopharmacol; 2013 Nov 01; 23(11):1636-44. PubMed ID: 23428338
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The anti-Parkinson drug budipine is exported actively out of the brain by P-glycoprotein in mice.
    Uhr M, Ebinger M, Rosenhagen MC, Grauer MT.
    Neurosci Lett; 2013 Nov 01; 383(1-2):73-6. PubMed ID: 15936515
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.